Bioscience companies rely more heavily on having an effective intellectual property portfolio than do companies based on other technologies. Often, the time required to reach product commercialization in biosciences is several years in the future. As a result, one of the greatest assets for the company is its intellectual property portfolio. Updated With Recent Court Decisions Affecting Patentability of Key Life Science Technologies. More information and online registration is here.